Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial

The SPYRAL HTN-OFF MED Pivotal trial (https://clinicaltrials.gov/ct2/show/NCT02439749) demonstrated significant reductions in blood pressure (BP) after renal denervation (RDN) compared to sham control in the absence of anti-hypertensive medications. Prior to the 3-month primary endpoint, medications...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Michael A., Schmieder, Roland E., Kandzari, David E., Townsend, Raymond R., Mahfoud, Felix, Tsioufis, Konstantinos, Kario, Kazuomi, Pocock, Stuart, Tatakis, Fotis, Ewen, Sebastian, Choi, James W., East, Cara, Lee, David P., Ma, Adrian, Cohen, Debbie L., Wilensky, Robert, Devireddy, Chandan M., Lea, Janice P., Schmid, Axel, Fahy, Martin, Böhm, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622517/
https://www.ncbi.nlm.nih.gov/pubmed/35852582
http://dx.doi.org/10.1007/s00392-022-02064-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622517/
https://www.ncbi.nlm.nih.gov/pubmed/35852582
http://dx.doi.org/10.1007/s00392-022-02064-5

Ejemplares similares